Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/10/25
End: 12/05/26
Due: 12/05/27
Phase: N/A
Priority: Normal
Start: 09/20/23
End: 03/19/24
Due: 03/19/25
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 12/30/25
Due: 12/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects | NCT06760455 | Chengdu Brilliant Pharmaceutical Co., Ltd. | user2@example.com | None | 2025-01-10 | 2026-12-05 | 2027-12-05 | - | - | 2025-07-14 |
| The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery | NCT06092684 | Chengdu Brilliant Pharmaceutical Co., Ltd. | user2@example.com | None | 2023-09-20 | 2024-03-19 | 2025-03-19 | - | - | 2025-07-14 |
| Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes | NCT06339086 | Chengdu Brilliant Pharmaceutical Co., Ltd. | user2@example.com | None | 2024-04-30 | 2025-12-30 | 2026-12-30 | - | - | 2025-07-14 |